Announcement of Company Name Change
Tokyo, April 3, 2017 – Panasonic Healthcare Holdings Co., Ltd. ("Panasonic Healthcare HD") and Panasonic Healthcare Co., Ltd. ("Panasonic Healthcare") have decided to change the company names (trade names) to PHC Holdings Corporation and PHC Corporation respectively. This will become effective April 2018.
In 2014, Panasonic Healthcare was carved out of the Panasonic group with external funding. Founded in 2014, Panasonic Healthcare HD acquired the Diabetes Care business of Bayer AG in 2016, which was established as Ascensia Diabetes Care Holdings AG ("Ascensia HD"), and since then has been steadily expanding business in more than 125 countries. In April 2018, the names of all group companies including domestic and overseas affiliates, with the sole exception of the Ascensia HD group, will be changed to the names that start with “PHC.”
In line with the company name change, Panasonic Healthcare HD will be changing current branding that use the “Panasonic” name. Multiple brands as shown below will be used to represent each business under the PHC corporate brand.
· New Company Name and Brand (effective April 2018)
About Panasonic Healthcare Holdings Co., Ltd.
Incorporated in 2014, Panasonic Healthcare Holdings Co., Ltd. (shareholder structure: KKR 58%, Mitsui & Co., Ltd. 22%, Panasonic Corporation 20%) is involved in developing, manufacturing, selling and servicing medical equipment and solutions through its subsidiaries, Panasonic Healthcare Co., Ltd. and Ascensia Diabetes Care Holdings AG. For further information on Panasonic Healthcare Holdings, please visit
About Panasonic Healthcare Co., Ltd.
Incorporated in 1969, Panasonic Healthcare contributes to the wellbeing of society by creating new value propositions for all the people who wish for better health, through its three core businesses for In Vitro diagnostics devices, Medical IT and Laboratory and Medical Support devices. For further information on Panasonic Healthcare, please visit
About Ascensia Diabetes Care Holdings AG
Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes. Our mission is to empower people living with diabetes through innovative solutions that simplify and improve their lives. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a positive, daily difference for people with diabetes.
Home to the world renowned CONTOUR® portfolio of blood glucose monitoring systems, our products combine advanced technology with user-friendly functionality that help people with diabetes to manage their condition. We are committed to continued research, innovation and development of new products and solutions. As a trusted partner in the diabetes community, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy, precision and reliability, and that we conduct our business compliantly and with integrity.
Ascensia Diabetes Care was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd. Ascensia Diabetes Care products are sold in more than 125 countries. Ascensia Diabetes Care has around 1,700 employees and operations in 33 countries. For further information please visit the Ascensia Diabetes Care website at: http://www.ascensia.com.